Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Corporate Insiders Are Selling These 5 Small-Cap Stocks

This article presents an overview of Corporate Insiders Are Selling These 5 Small-Cap Stocks. For a detailed overview of such stocks, read our article, Corporate Insiders Are Selling These 10 Small-Cap Stocks.

5. Couchbase Inc (NASDAQ:BASE)

Number of Hedge Fund Investors: 19

Database software company Couchbase Inc (NASDAQ:BASE) ranks fifth in our list of the small-cap stocks insiders are selling. Couchbase Inc’s (NASDAQ:BASE) CFO Greg Henry on March 21 dumped 18,747 shares of Couchbase Inc (NASDAQ:BASE) at $27.84. Since then the stock is down about 5.18%.

Out of the 933 funds tracked by Insider Monkey, 19 hedge funds reported owning stakes in Couchbase Inc (NASDAQ:BASE) at the end of the fourth quarter of 2023, up from 12 funds in the previous quarter.

4. Ryerson Holding Corp. (NYSE:RYI)

Number of Hedge Fund Investors: 19

Industrial metals company Ryerson Holding Corp. (NYSE:RYI) is one of the small-cap stocks with latest insider selling transactions. Ryerson Holding Corp.’s (NYSE:RYI) Chief Information Office Alagu Sundarrajan dumped 6,932 shares of Ryerson Holding Corp. (NYSE:RYI) on March 22 at $32.76 per share. He also sold 2,593 shares of Ryerson Holding Corp. (NYSE:RYI) on March 25 at $32.52 a piece. Since March 22 Ryerson Holding Corp. (NYSE:RYI) shares are down 0.4%.

3. Phreesia Inc (NYSE:PHR)

Number of Hedge Fund Investors: 20

Phreesia Inc (NYSE:PHR) makes software solutions for the healthcare industry. Phreesia Inc’s (NYSE:PHR) COO Evan Roberts on March 21 unloaded 25,962 shares of Phreesia Inc (NYSE:PHR) at $23.52 per share. Since March 21 through March 26 the stock is almost flat.

Conestoga Capital Advisors Micro Cap Strategy stated the following regarding Phreesia, Inc. (NYSE:PHR) in its fourth quarter 2023 investor letter:

“Phreesia, Inc. (NYSE:PHR): PHR, a leader in patient intake software to the medical industry, had a strong rebound in the fourth quarter after being a laggard in the third quarter. PHR reported a strong third quarter, with margins and adjusted EBITDA significantly beating expectations. PHR’s management also pivoted their financial model with the introduction of their 2024 guidance, reflecting an increased focus on profitability, which came in materially ahead of expectations. Revenue growth guidance moderated but is still projected at greater than 20%.”

2. Vita Coco Company Inc (NASDAQ:COCO)

Number of Hedge Fund Investors: 23

Coconut water company Vita Coco Company Inc (NASDAQ:COCO) is one of the small-cap stocks with latest insider selling. Vita Coco Company Inc’s (NASDAQ:COCO) COO Jonathan Burth on March 12 sold 45,000 shares of Vita Coco Company Inc (NASDAQ:COCO) at $25.02 per share. Vita Coco Company Inc’s (NASDAQ:COCO) cofounder and board member Ira Liran also sold 46,303 shares of Vita Coco Company Inc (NASDAQ:COCO) on March 19 at $25.02 per share. Since then Vita Coco Company Inc (NASDAQ:COCO) shares have lost about 4.53%.

1. Mirum Pharmaceuticals Inc (NASDAQ:MIRM)

Number of Hedge Fund Investors: 33

California-based Mirum Pharmaceuticals Inc (NASDAQ:MIRM) works on treatments for rare diseases. Mirum Pharmaceuticals Inc’s (NASDAQ:MIRM) Chief Operating Officer Peter Radovich on March 25 sold 4,303 shares of Mirum Pharmaceuticals Inc (NASDAQ:MIRM) for $25.80 per share. Since this transaction the stock price has lost about 4.7% in value.

ClearBridge Small Cap Growth Strategy stated the following regarding Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) in its fourth quarter 2023 investor letter:

“In the fourth quarter we initiated four new investments: Inari Medical, Blackbaud, Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) and Installed Building Products. Mirum Pharmaceuticals is a commercial stage pharmaceutical company primarily treating rare liver conditions, often in pediatric patients. With multiple approved marketed products across different indications, the company is already operating near cash[1]flow breakeven. Mirum is pursuing label indication expansions across two of its marketed products that could be materially additive to the growth trajectory, along with two promising Phase 2 candidates designed to treat several adult rare liver diseases.”

Should you invest $1,000 in Mirum Pharma right now?

Before you buy stock in MIRM, consider this:

The Insider Monkey Quarterly Newsletter just identified what we believe are the 14 best stocks for investors to buy now… and MIRM wasn’t one of them. The 14 stocks that made the cut could produce monster returns in the next few months.

Quarterly Newsletter is your easy-to-follow blueprint for building a winning portfolio.  It includes stock picks from billionaires, regular updates from hedge fund investor letters, and 14 fresh stock picks each quarter. The Quarterly Newsletter service has more than doubled the return of S&P 500 since 2014.

See the 14 stocks

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks and the 10 Mining Stocks with Heavy Insider Buying in 2024.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.